1992;54:479 83. 1120. Kiyama H, Ohshima N, Imazeki T, et al. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg. 1999;68:1652 6. 1121. Gombotz H. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol. 1996;33:69 70. 1122. Weltert L, D Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010;139:621 6. 1123. Alghamdi AA, Albanna MJ, Guru V, et al. Does the use of erythro- poietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg. 2006;21:320 6. 1124. Rosengart TK, Helm RE, Klemperer J, et al. Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah s Wit- nesses. Ann Thorac Surg. 1994;58:1397 403. 1125. Gaudiani VA, Mason HD. Preoperative erythropoietin in Jehovah s Witnesses who require cardiac procedures. Ann Thorac Surg. 1991;51: 823 4. 1126. Bardakci H, Cheema FH, Topkara VK, et al. Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. Ann Thorac Surg. 2007;83:483 9. 1127. Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients or 80 years: results from the National Cardio- vascular Network. J Am Coll Cardiol. 2000;35:731 8. 1128. Engoren M, Arslanian-Engoren C, Steckel D, et al. Cost, outcome, and functional status in octogenarians and septuagenarians after cardiac surgery. Chest. 2002;122:1309 15. 1129. Filsoufi F, Rahmanian PB, Castillo JG, et al. Results and predictors of early and late outcomes of coronary artery bypass graft surgery in octogenarians. J Cardiothorac Vasc Anesth. 2007;21:784 92. 1130. Scott BH, Seifert FC, Grimson R, et al. 